Posted by Admin | 2:39 PM

The march of legal settlements made by big health care organizations has resumed with a bang.  As reported in most major media outlets, gian...

Labels: crime, deception, impunity, Johnson and Johnson, kickbacks, legal settlements, marketing

Posted by Admin | 12:54 PM

Our latest example of the interchangeability of top insiders within corporate health care and the government agencies that are supposed to r...

Labels: CMS, corporatism, DHHS, FDA, Johnson and Johnson, revolving doors

Posted by Admin | 10:38 AM

Very quietly, pharmaceutical/ biotechnology/ medical device corporate giant Johnson & Johnson just settled another lawsuit. The most pi...

Labels: adulterated drugs, deception, executive compensation, Johnson and Johnson, legal settlements, manufacturing problems

Posted by Admin | 5:00 AM

And the latest Johnson & Johnson settlement is (as described in Bloomberg/ BusinessWeek): Johnson & Johnson (JNJ) will pay $181 mill...

Labels: corporate royalty, deception, imperial CEO, Johnson and Johnson, kickbacks, legal settlements, Risperdal, William Weldon

Posted by Admin | 8:51 AM

The latest legal black eye for giant pharmaceutical and device company Johnson and Johnson appeared in an Arkansas court room.  As documente...

Labels: crime, deception, fraud, Janssen, Johnson and Johnson, legal settlements, Risperdal

Posted by Admin | 12:00 PM

More justifications of physicians' and other health care professionals' financial arrangements with industry have been appearing in ...

Labels: Biomet, bribery, conflicts of interest, deferred prosecution agreement, health care corruption, Johnson and Johnson, legal settlements, Smith and Nephew

Posted by Admin | 9:16 AM

After 30 separate product recalls since 2009, and multiple legal settlements and guilty pleas, we noted that the former pharmaceutical repr...

Labels: executive compensation, golden parachutes, Johnson and Johnson, marketing, mission-hostile management, perverse incentives

Posted by Admin | 12:47 PM

The extremely well compensated CEO and Chairman of Johnson and Johnson, the huge and recently hugely troubled US based pharmaceutical and de...

Labels: executive compensation, generic management, generic managers, Johnson and Johnson, marketing, mission-hostile management, perverse incentives

Posted by Admin | 2:12 PM

Before it was abruptly ended by a sudden settlement for $158 million, the trial in Texas of a suit alleging unethical marketing of the drug ...

Labels: conflicts of interest, deception, evidence-based medicine, ghostwriting, intimidation, Johnson and Johnson, key opinion leaders, Risperdal, stealth marketing